| NCT03581149 |
Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patients |
PHASE4 |
UNKNOWN |
American University of Beirut Medical Center |
Ulcerative Colitis |
DRUG: Sodium Picosulfate/Magnesium Citrate Laxati… |
Details |
| NCT05726097 |
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure |
PHASE3 |
COMPLETED |
Region Skane |
Colon Cancer; Inflammatory Bowel Diseases; Gastro… |
DRUG: polyethylene glycol; DRUG: sodium phosphate… |
Details |
| ChiCTR2200056969 |
Efficacy, tolerability and safety of Sodium picosulphate/magnesium citrate versus 3-L polyethylene glycol for bowel preparation for patients with Inflammatory Bowel Disease |
Not Available |
Recruiting |
Shenzhen Hospital of Southern Medical University |
Bowel preparation |
Experimental group:intake sodium picosulfate/magn… |
Details |
| JPRN-UMIN000046015 |
A prospective, controlled, randomized, assessor-blind, comparative study of a new oral bowel cleanser (Sodium Picosulfate/Magnesium Citrate) versus existing oral bowel cleanser (Magnesium Citrate) in pediatric colonoscopy preparation. - A prospective, controlled, randomized, assessor-blind, comparative study of a new oral bowel cleanser (Sodium Picosulfate/Magnesium Citrate) versus existing oral bowel cleanser (Magnesium Citrate) in pediatric colonoscopy preparation. |
Not Available |
Not Recruiting |
Saitama children's Medical Center Division of Gastroenterology and Hepatology |
Inflammatory bowel disease, Functional gastrointe… |
PICOPREP MAGCOROL Powder |
Details |
| NCT03593252 |
Mechanical Bowel Prep and Prophylactic Oral Antibiotic Use in Children: Implications for Intestinal Surgery Complications |
Not Available |
Not recruiting |
McMaster University |
Colostomy Stoma;Ileostomy - Stoma;Jejunostomy Sto… |
Drug: Senna;Drug: Sodium Picosulfate, Magnesium O… |
Details |
| ACTRN12618000617268 |
The use and efficacy of transabdominal ultrasound to assess bowel preparation prior to colonoscopy to avoid unnecessary repeat colonoscopies. |
Not Available |
Not Recruiting |
Concord Hospital Gastroenterology Department |
Crohn's disease;Ulcerative Colitis;Colonoscopy pr… |
Whether transabdominal ultrasound can accurately … |
Details |
| NCT02009202 |
Preparation Prior to Colonoscopy in Children |
None |
COMPLETED |
Skane University Hospital |
Inflammatory Bowel Diseases |
DRUG: polyethylene glycol; DRUG: picosulphate |
Details |
| NCT02227602 |
Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease |
None |
COMPLETED |
Texas A&M University |
Intestinal Diseases|Ulcerative Colitis|Crohn Dise… |
DRUG: Mango polyphenolics |
Details |
| CTRI/2021/10/037641 |
An open label study to compare the efficacy and safety of tofacitinib compared to corticosteroids for inducing remission in moderately severe active ulcerative colitis |
PHASE4 |
Recruiting |
Dayanand Medical College and Hospital Ludhiana |
Disease.2. Total mayo clinic score <6 or >9. 3.… |
Health Condition 1: K51- Ulcerative colitis |
Details |
| ISRCTN11169656 |
Moderate wine consumption and digestive function: intestinal microbiota, metabolic functionality and effect on the clinical symptoms of patients with inflammatory bowel disease |
Not Available |
Not Recruiting |
Institute of Food Science Research |
Ulcerative colitis Digestive System Ulcerative … |
People were allocated randomly at the hospital to… |
Details |
| NCT05575505 |
Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis. |
PHASE2 |
RECRUITING |
Tanta University |
Inflammatory Bowel Diseases |
DRUG: Pentoxifylline 400 MG |
Details |
| NCT06651281 |
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) |
PHASE3 |
RECRUITING |
Merck Sharp & Dohme LLC |
Crohn Disease|Colitis, Ulcerative |
DRUG: Tulisokibart|DRUG: Placebo to tulisokibart |
Details |
| NCT06681181 |
A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK4528287 in Healthy Participants |
PHASE1 |
RECRUITING |
GlaxoSmithKline |
Colitis, Ulcerative |
DRUG: GSK4528287|DRUG: Placebo |
Details |
| NCT04478825 |
Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis |
PHASE1 |
TERMINATED |
Bridge Biotherapeutics, Inc. |
Ulcerative Colitis |
DRUG: BBT-401-1S |
Details |
| NCT06321887 |
EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD |
PHASE3 |
RECRUITING |
Liverpool University Hospitals NHS Foundation Trust |
Inflammatory Bowel Disease|Iron Deficiency Anemia |
DRUG: Ferrous fumarate syrup 2.5ml/70mg (22.5mg e… |
Details |
| NCT02447302 |
Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis |
PHASE2 |
COMPLETED |
Arena Pharmaceuticals |
Ulcerative Colitis |
DRUG: Etrasimod|DRUG: Placebo |
Details |
| NCT05507203 |
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 |
PHASE3 |
RECRUITING |
Abivax S.A. |
Ulcerative Colitis |
DRUG: ABX464|DRUG: Placebo |
Details |
| NCT04677179 |
A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) |
PHASE2 |
TERMINATED |
Nektar Therapeutics |
Colitis, Ulcerative |
DRUG: LY3471851|DRUG: Placebo |
Details |
| NCT05177835 |
Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis |
PHASE2 |
ACTIVE_NOT_RECRUITING |
Abivax S.A. |
Ulcerative Colitis |
DRUG: ABX464 |
Details |
| NCT04348890 |
Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis |
PHASE1|PHASE2 |
WITHDRAWN |
ReveraGen BioPharma, Inc. |
Pediatric Ulcerative Colitis |
DRUG: Vamorolone 4% suspension for oral dosing |
Details |
